- Home
- JOB vs RNAZ Comparison
JOB vs RNAZ Comparison
Compare JOB & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JOB | RNAZ |
|---|---|---|
| Founded | 1893 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.7M | 27.9M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | JOB | RNAZ |
|---|---|---|
| Price | $6.56 | $1.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 163.8K | 21.9K |
| Earning Date | 12-16-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $96,504,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.18 | $1.33 |
| 52 Week High | $8.37 | $12.60 |
Technical Indicators
Market Signals| Indicator | JOB | RNAZ |
|---|---|---|
| Relative Strength Index (RSI) | 81.63 | 33.61 |
| Support Level | $6.36 | N/A |
| Resistance Level | $6.62 | $1.93 |
| Average True Range (ATR) | 0.16 | 0.14 |
| MACD | 0.85 | -0.01 |
| Stochastic Oscillator | 97.07 | 8.62 |
Price Performance
Historical ComparisonAbout JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.